IL39323A - Highly sensitive assay method employing an enzyme for amplification - Google Patents

Highly sensitive assay method employing an enzyme for amplification

Info

Publication number
IL39323A
IL39323A IL39323A IL3932372A IL39323A IL 39323 A IL39323 A IL 39323A IL 39323 A IL39323 A IL 39323A IL 3932372 A IL3932372 A IL 3932372A IL 39323 A IL39323 A IL 39323A
Authority
IL
Israel
Prior art keywords
amplification
enzyme
highly sensitive
assay method
method employing
Prior art date
Application number
IL39323A
Other languages
English (en)
Other versions
IL39323A0 (en
Original Assignee
Syva Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syva Co filed Critical Syva Co
Publication of IL39323A0 publication Critical patent/IL39323A0/xx
Publication of IL39323A publication Critical patent/IL39323A/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948—Sedatives, e.g. cannabinoids, barbiturates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/946—CNS-stimulants, e.g. cocaine, amphetamines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL39323A 1971-05-14 1972-04-28 Highly sensitive assay method employing an enzyme for amplification IL39323A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14360971A 1971-05-14 1971-05-14

Publications (2)

Publication Number Publication Date
IL39323A0 IL39323A0 (en) 1972-06-28
IL39323A true IL39323A (en) 1975-08-31

Family

ID=22504809

Family Applications (1)

Application Number Title Priority Date Filing Date
IL39323A IL39323A (en) 1971-05-14 1972-04-28 Highly sensitive assay method employing an enzyme for amplification

Country Status (12)

Country Link
JP (1) JPS5327763B1 (de)
BR (1) BR7202989D0 (de)
CA (1) CA1003770A (de)
CH (1) CH553410A (de)
DE (1) DE2223385C3 (de)
ES (1) ES402720A1 (de)
FR (1) FR2139505A5 (de)
GB (2) GB1401298A (de)
IL (1) IL39323A (de)
IT (1) IT972332B (de)
NL (1) NL170564C (de)
SE (1) SE403190B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1028643A (en) * 1975-02-20 1978-03-28 Judith I. Blakemore Polylodothyronine immunoassay
US4104367A (en) * 1976-10-13 1978-08-01 Hoffmann-La Roche Inc. Radioimmunoassay for methadone
US4220450A (en) * 1978-04-05 1980-09-02 Syva Company Chemically induced fluorescence immunoassay
DE2923139A1 (de) * 1979-06-07 1980-12-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von immunologisch aktiven enzymmarkierten konjugaten
EP0040224A4 (de) * 1979-11-19 1982-09-09 Prince Charles Hospital Dev Ct Verbessertes analyseverfahren für nichthomogene enzyme.
GB2120785A (en) * 1982-05-26 1983-12-07 Celltech Ltd Enzyme immunoassay
GB8407736D0 (en) * 1984-03-26 1984-05-02 Univ London Detecting specific polynucleotide sequences
IT1178788B (it) * 1984-12-21 1987-09-16 Sclavo Spa Metodo immunoenzimatico per la determinazione di analiti e composizione adatti allo scopo
US4833073A (en) * 1987-01-27 1989-05-23 Hoffmann-La Roche Inc. Immunoassay for tetrahydrocannabinol metabolites
US5374524A (en) * 1988-05-10 1994-12-20 E. I. Du Pont De Nemours And Company Solution sandwich hybridization, capture and detection of amplified nucleic acids
US5137804A (en) * 1988-05-10 1992-08-11 E. I. Du Pont De Nemours And Company Assay device and immunoassay
US5196306A (en) * 1989-03-29 1993-03-23 E. I. Du Pont De Nemours And Company Method for the detection or quantitation of an analyte using an analyte dependent enzyme activation system
EP2418492B1 (de) * 2010-08-10 2018-10-10 Randox Laboratories Ltd. Immunoreagens für Meprobamate

Also Published As

Publication number Publication date
IT972332B (it) 1974-05-20
ES402720A1 (es) 1976-12-01
DE2223385A1 (de) 1973-01-04
NL170564B (nl) 1982-06-16
NL7206434A (de) 1972-11-16
CH553410A (fr) 1974-08-30
GB1401297A (en) 1975-07-16
FR2139505A5 (de) 1973-01-05
DE2223385C3 (de) 1984-10-25
IL39323A0 (en) 1972-06-28
BR7202989D0 (pt) 1973-11-01
DE2223385B2 (de) 1979-02-22
NL170564C (nl) 1982-11-16
GB1401298A (en) 1975-07-16
JPS5327763B1 (de) 1978-08-10
SE403190B (sv) 1978-07-31
CA1003770A (en) 1977-01-18

Similar Documents

Publication Publication Date Title
CA970305A (en) Enzyme reactor
CA942992A (en) Enzyme modified protein process
IL42123A0 (en) Substrate for the determination of proteolytic enzymes
IL42124A0 (en) Substrate for the determination of proteolytic enzymes
BR7203397D0 (pt) Enzima protolitica alcalina
IL39323A0 (en) Highly sensitive assay method employing an enzyme for amplification
ZA72619B (en) Enzymes
AU3358471A (en) Enzymes
AU6020273A (en) Immobilized enzymes
CA960207A (en) Method for detecting geopressures
CA922321A (en) Enzyme inhibitors
CA946837A (en) Enzyme inhibitor
AU468613B2 (en) Improved precipitating solution for & amylase assay
IL41133A0 (en) Milk-clotting enzyme
CA946836A (en) Enzyme inhibitor
CA984015A (en) Isolation amplifier
CA862894A (en) Two-valley semiconductor amplifier
CA970871A (en) Temperature detecting system
CA866371A (en) Polarographic sensor
CA863297A (en) Specific detection method for cyanide
CA893252A (en) Diffusion method for the determination of enzymes
IL35973A0 (en) Proximity sensitive system
ZM13971A1 (en) Enzyme inhibitor
CA1002518A (en) Enzyme inhibitor
CA815010A (en) Assay method for amylase